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Abstract The subcellular localization of the human Ca2+-
binding EF-hand/leucine zipper protein NEFA was studied in
HeLa cells by immunofluorescence microscopy. Double immu-
nostaining using mouse anti-NEFA monoclonal antibody
1H8D12 and rabbit anti-ERD2 polyclonal antibody proved that
NEFA is localized in the Golgi apparatus. The result was
confirmed by the expression of NEFA^green fluorescent protein
(GFP) fusion protein in the Golgi in the same cell line.
Cycloheximide treatment proved NEFA to be a Golgi-resident
protein. Seven NEFA deletion mutants were constructed to
ascertain the peptide region relevant for Golgi retention. The
expression of each NEFA^GFP variant was detected by
fluorescence microscopy and immunoblotting. Only the vN
mutant, lacking the N-terminal Leu/Ile-rich region, failed to be
retained in the Golgi after cycloheximide treatment. The other
six deletion mutants in which either the basic region, the
complete EF-hand pair domain, the two EF-hand motifs
separately, the leucine zipper and the leucine zipper plus the C-
terminal region is deleted, were localized to the Golgi. The
peptide sequence within the Leu/Ile-rich region is discussed as a
novel Golgi retention motif. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The human NEFA protein was originally identi¢ed in the
common acute lymphoblastic leukemia cell line KM3 [1]. The
NEFA precursor protein consists of 420 amino acid residues.
It is a mosaic protein composed of seven regions. From the N-
to the C-terminus the sequences are arranged as follows: a 24-
residue signal peptide, a leucine/isoleucine (Leu/Ile)-rich re-
gion of 148 residues, a basic putative DNA-binding domain
with a potential bipartite nuclear targeting signal, an EF-hand
1 motif, the acidic region, an EF-hand 2 motif and the leucine
zipper region (Fig. 3). Mature NEFA protein was isolated
from crude membranes and cytosolic fractions of KM3 cells.
Its apparent relative molecular mass on sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis (SDS^PAGE) is 55
kDa [1,2]. NEFA protein binds Ca2-ions via its EF-hand
domain at a ratio of 2 mol Ca2/mol protein, hereby increas-
ing its K-helical content [3].
Recently, the Drosophila melanogaster homolog was ana-
lyzed from mRNA of Oregon-R embryos and adult £ies
and also from the genomic DNA of the £y. Its expression
was detected speci¢cally in the larvae salivary glands and in
the placodes from embryonal stage 11 onwards [4].
The biological role of NEFA is unknown up to now.
NEFA shows strong sequence homology to the other EF-
hand/leucine zipper protein nucleobindin (NUC) [1].
Murine NUC was detected and studied as a soluble factor
promoting anti-DNA autoimmune responses in MRL/lpr (lu-
pus-prone) mice [5,6], and the exon^intron structure of the
human placental NUC gene has been reported [7]. Bovine
NUC was studied as an extracellular bone matrix protein,
in parallel rat NUC from calvaria was analyzed [8]. It was
suggested that NUC may be involved in osteoid mineraliza-
tion of bone. Rat NUC, synonym CALNUC, derived from
GC (GH3) pituitary cells [9], was described as an abundant
Golgi-resident protein, being involved in Ca2 homeostasis in
the Golgi compartment [10]. Rat CALNUC was found to
interact with the G-protein GKi3 via its EF-hand domain
[11]. Murine NUC had been shown to interact with GKi2
[12], and also with the cyclooxygenases COX-1 and COX-2
[13]. Co-overexpression of NUC and COX-1 or COX-2 re-
duced the NUC secretion level in COS-1 kidney cells. CAL-
NUC from the lepidopteran insect Spodoptera frugiperda
SF21 ovary cell line was detected in cis-Golgi compartments
[14].
Recently, the postmitotic growth suppressor Necdin was
described as interaction partner of murine NEFA and
NUC. The coexpression of Necdin and NEFA was studied
in undi¡erentiated P19 embryonic carcinoma cells and in via
retinoic acid induction derived neuronal di¡erentiated P19
cells. Elevated levels of both proteins were detected in the
postmitotic neurons. Necdin binds to the NEFA EF-hand
domain [15].
Here we present the subcellular localization of human
NEFA in HeLa cells.
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2. Materials and methods
2.1. Plasmid construction
The plasmid pEGFP-N1 was obtained from Clontech, restric-
tion enzymes and ligase from Gibco/BRL and Vent polymerase
used for all polymerase chain reactions (PCRs) from New England
Biolab.
The coding sequence of NEFA was ampli¢ed by PCR from NEFA
cDNA clone Hir25 adding cleavage site XhoI at the 5P-end and PstI at
the 3P-end using NeXhoI(f) and NePstI(r) as primers listed below.
Seven variants lacking either the N-terminus (vN), the basic region
(vB), the EF-hand 1 plus acidic amino acid-rich region plus EF-hand
2 (vEAE), the single EF-hands (vEF1 and vEF2), the leucine zipper
(vL) and the leucine zipper plus the C-terminal region (vLC) respec-
tively, were constructed. The coding sequence of the vLC variant was
ampli¢ed by PCR using NeXhoI(f) and vLCPstI(r) as primers. For
the construction of each of the six remaining variants two fragments
containing the coding sequence from the 3P-end and the 5P-end to the
depletion site, omitting the motif to be deleted, were ampli¢ed by
PCR. Primers used were NeXhoI(f) and the appropriate Rev1 for
each variant for the 5P-end fragment and For1 as well as NePstI(r)
for the 3P-end fragment. PCR products of these PCRs were puri¢ed
and used as templates in a second set of PCRs. Here, overlapping
ends were added to the fragments using primers containing a nucleo-
tide sequence homolog to 21 bp of the 5P-end of the 3P-end fragment
as well as 21 bp of the 3P-end of the 5P-end fragment. Primers used
were NeXhoI(f) and the appropriate Rev2 primer for the 5P-end frag-
ment and For2 as well as NePstI(r) for the 3P-end fragment. The PCR
products were again puri¢ed. The two fragments of each variant were
now subjected to an assembly PCR. The ¢rst two cycles were run
without any primers to leave time for annealing of the overlapping
ends of the two fragments, thus forming the complete coding sequence
of the variant. Then the primers NeXhoI(f) and NePstI(r) were added
to amplify the sequence.
The PCR products of these six assembly PCRs, the vLC and the
coding sequences of wild-type NEFA were puri¢ed by gel electropho-
resis and cloned into the pEGFP-N1 vector after digestion by XhoI
and PstI. The recombinant plasmids were transformed into Escheri-
chia coli DH5K. The open reading frame of the recombinant plasmids
was veri¢ed by DNA sequencing on ABI Prism 377 (Applied Biosys-
tems).
2.2. Primers
Terminal 5P-end and 3P-end primers:NeXhoI(f), 5P-TTATTCTC-
GAGCCTGAACATGAGGTGGAGGA-3P ; NePstI(r), 5P-GAACCT-
CTGCAGAATGTGTGGCTCAAACTTCAATT-3P ; vLCPstI(r), 5P-
GAACCTCTGCAGTTTTTTTTCTGTGGCTTTCAA-3P ; XhoI and
PstI cleavage sites are underlined.
Reverse primer 1 (Rev1): vNr1, 5P-AGCTTCAAGAGCAGTAAG-
TAA-3P ; vBr1, 5P-GTCATAGTGTTCCAGATCACT-3P ; vEAEr1,
5P-AAAGTCATTAGGATCCAATCC-3P ; vEF1r1, 5P-AAAGTCAT-
TAGGATCCAATCC-3P ; vEF2r1, 5P-TCTAAGCCTTTCTTCTTC-
CAT-3P ; vLr1, 5P-TTCTTCCTCTGTGAAGAACTG-3P. Forward
primer 1 (For1): vNf1, 5P-AAGACTCGTCATGAAGAATTT-3P ;
vBf1, 5P-GGAAGCAAAGATCAACTAAAA-3P ; vEAEf1, 5P-GAA-
TTCTTGGAGCCAGATAGC-3P ; vEF1f1, 5P-TTGGAGAAAGTA-
TATGACCCT-3P ; vEF2f1, 5P-GAATTCTTGGAGCCAGATAGC-
3P ; vLf1, 5P-GAGGCTCAGAAGCTGGAATAT-3P. Reverse primer
2 (Rev2): vNr2, 5P-AAATTCTTCATGACGAGTCTTAGCTTC-
AAGAGCAGTAAGTAA-3P ; vBr2, 5P-TTTTAGTTGATCTTTGC-
TTCCGTCATAGTGTTCCAGATCACT-3P ; vEAEr2, 5P-GCTAT-
CTGGCTCCAAGAATTCAAAGTCATTAGGATCCAATCC-3P ;
vEF1r2, 5P-AGGGTCATATACTTTCTCCAAAAAGTCATTAGG-
ATCCAATCC-3P ; vEF2r2, 5P-GCTATCTGGCTCCAAGAATTCT-
CTAAGCCTTTCTTCTTCCAT-3P ; vLr2, 5P-ATATTCCAGCTTC-
TGAGCCTCTTCTTCCTCTGTGAAGAACTG-3P. Forward primer
2 (For2): vNf2, 5P-TTACTTACTGCTCTTGAAGCTAAGACTCG-
TCATGAAGAATTT-3P ; vBf2, 5P-AGTGATCTGGAACACTAT-
GACGGAAGCAAAGATCAACTAAAA-3P ; vEAEf2, 5P-GGATT-
GGATCCTAATGACTTTGAATTCTTGGAGCCAGATAGC-3P ;
vEF1f2, 5P-GGATTGGATCCTAATGACTTTTTGGAGAAAGTA-
TATGACCCT-3P ; vEF2f2, 5P-ATGGAAGAAGAAAGGCTTAGA-
GAATTCTTGGAGCCAGATAGC-3P ; vLf2, 5P-CAGTTCTTCA-
CAGAGGAAGAAGAGGCTCAGAAGCTGGAATAT-3P.
2.3. Antibodies
The rabbit anti-NEFA polyclonal antibody (pAb) Gu1 and the
murine anti-NEFA monoclonal antibody (mAb) 1H8D12 of BALB/c
mice, were generated in our laboratory against the recombinant
human NEFA protein (rNEFA), heterologously expressed in Pichia
pastoris. The pAb Gu1 was puri¢ed by a⁄nity chromatography on
Sepharose column coupled with rNEFA. The rabbit anti-ERD2 pAb
was a kind gift of Prof. Dr. H-D. So« ling, Department of Neurobiol-
ogy, Max-Planck-Institute for Biophysical Chemistry, Go«ttingen, Ger-
many [16]. Fluorescein isothiocyanate (FITC)-conjugated rabbit anti-
mouse immunoglobulin pAb and tetramethylrhodamine isothiocya-
nate (TRITC)-conjugated porcine anti-rabbit immunoglobulin pAb
were purchased as secondary antibodies from Sigma.
2.4. Double immunolabeling
Adherent growing HeLa cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium containing 10% fetal calf serum, 50 Wg/ml streptomy-
cin and 100 Wg/ml penicillin G under 5% CO2 on slides using silicon
coverslips. After 24 h the cells were washed in phosphate-bu¡ered
saline (PBS) and ¢xed with 8% paraformaldehyde. Fixed cells were
labeled with mAb 1H8D12 at a dilution of 1:20 and subsequently
with FITC-conjugated secondary antibody at a dilution of 1:200.
Further cells were labeled with anti-ERD2 pAb at a dilution of
1:100 and subsequently with TRITC-conjugated secondary antibody.
For the staining of the nuclei Hoechst H33342 dye was added to the
last secondary antibody at 500 Wg/ml. The cells were then analyzed
with a £uorescence microscope (Axioskop, Zeiss).
2.5. Transfection
Cells cultured for 24 h on slides, as described above, were trans-
fected for 2 h with 1.5 Wg recombinant plasmid DNA dissolved in 7.5
Wl SuperFect Transfection Reagent (Qiagen) according to the manu-
factural protocol. Prior to transfection the plasmid DNA was puri¢ed
by Qiagen’s Midi prep kit. The cells were ¢xed with 8% paraformal-
dehyde 24 h after beginning of the transfection. Fixed cells were
labeled with anti-ERD2 pAb at a dilution of 1:100 and TRITC-con-
jugated secondary antibody to visualize the cis-Golgi compartment.
Nuclei were stained by adding Hoechst H33342 dye. 24 h post-trans-
fection the cells were treated with cycloheximide at a concentration of
60 Wg/ml to block translation and then incubated at 37‡C for up to 4 h
[17]. The expression of protein NEFA was detected by £uorescence
microscopy and immunoblotting.
2.6. Immunoblotting
5U105 cells were transfected in 75 ml culture £asks (Nunc) with the
superfection kit using 9 Wg plasmid DNA and 30 Wl SuperFect reac-
tion mix. 24 h later the cells were lysed with 1 ml Laemmli loading
bu¡er containing 2.3% (w/v) SDS for 10 min at 100‡C. After a short
centrifugation step the cleared protein extracts were transferred to
SDS^PAGE and subsequently electroblotted onto PVDF membrane
[18]. The mAb IH8D12 or pAb Gu1 were added at dilutions of 1:200
and 1:1000, respectively, for immunodetection using the ECL system
from Amersham Pharmacia Biotech.
3. Results
3.1. The subcellular localization of human NEFA
HeLa cells grown on slides were labeled with anti-human
NEFA mAb 1H8D12 and anti-ERD2 pAb. NEFA was de-
tected as epinuclear deposits (Fig. 1A and B), overlapping
with the red £uorescence of the KDEL receptor protein
ERD2, which marked the Golgi complex (Fig. 1C, yellow;
Fig. 1D, red). In some cells also in the cytosol slight staining
of NEFA was detectable. The result indicates that NEFA is
localized in the Golgi apparatus.
3.2. The expression of NEFA^green £uorescent protein (GFP)
fusion protein and its deletion mutants
The complete open reading frame of NEFA cDNA except
the stop codon was fused to the 5P-end of the GFP gene in the
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vector pEGFP-N1. The recombinant plasmid was transfected
in HeLa cells and its expression was detected by £uorescence
microscopy 24 h post-transfection directly in vital as well as in
paraformaldehyde-¢xed cells. Additionally, the ¢xed HeLa
cells were labeled with the anti-ERD2 pAb and the Hoechst
H33342 dye. The NEFA^GFP fusion protein accumulated
epinuclear and overlapped with the ERD2 protein (Fig. 2a^
d). This coincides with immunodetection of the endogenous
Fig. 1. Immuno£uorescence staining of NEFA in HeLa cells. Fixed cells were labeled with anti-human NEFA mAb 1H8D12 stained by FITC
(green), with anti-ERD2 pAb stained by TRITC (red) and with nuclear stain Hoechst H33342 (blue). A: NEFA (green). B: NEFA (green) and
nuclei (blue). C: Overlapped staining NEFA plus ERD2 (yellow interference). D: ERD2 (red).
Fig. 2. Fluorescence microscopy analyses of the expression of NEFA^GFP fusion protein in HeLa cells. At 24 h after transfection the cells
were ¢xed and labeled with anti-ERD2 pAb and TRITC, and with Hoechst H33342. a: Green £uorescing NEFA^GFP fusion protein in the
transfected HeLa cells. b: NEFA^GFP (green) and nuclei, stained by Hoechst H33342 (blue). c: Overlapped staining NEFA^GFP plus ERD2
(yellow interference). e: GFP (green). f : GFP (green) and Hoechst H33342 (blue).
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native NEFA, shown in Fig. 1. Thus, NEFA is localized in
the Golgi. The expressed fusion protein was veri¢ed by im-
munoblotting of whole cell lysates 24 h post-transfection (see
Fig. 4). The transfection rate of the recombinant plasmid
pEGFP-N1-NEFA was 15^30%. The cells could be held in
cell culture for maximal 3 days, showing morphological alter-
ations like vacuolization and rounded cell shapes. For control
experiments HeLa cells were transfected only by the vector
pEGFP-N1. The transfection rate also was 15^30%, and as
expected, GFP was detected all-over the cell (Fig. 2e). The
GFP-transfected HeLa cells remained in culture longer than
3 days, showing no remarkable morphological alterations.
To elucidate the stability of the binding of NEFA in the
Golgi apparatus the NEFA^GFP-transfected cells were
treated with cycloheximide 24 h post-transfection. After incu-
bation for 2 h and 4 h at 37‡C the cells were ¢xed and the
expression of the NEFA^GFP fusion protein was ascertained
by £uorescence microscopy. The experiments were carried out
in parallel with the seven di¡erent deletion mutants of NEFA
in order to characterize the region which is engaged in the
location of NEFA in the Golgi. The deletion mutant con-
structs are summarized in Fig. 3.
All seven mutant NEFA^GFP fusion proteins were ex-
pressed in HeLa cells and the expressed proteins were checked
by immunoblotting of the cell lysates 24 h post-transfection,
as shown in Fig. 4. The transfection rates of the pEGFP-N1-
NEFA mutants were similar to that of the wild type. The
transfected HeLa cells generally survived for at least 3 days
in culture.
The expression of wild-type NEFA^GFP fusion protein
and the deletion mutants, vN lacking the N-terminal Leu/
Ile-rich region, vEAE lacking the complete EF-hand domain
and vL lacking the leucine zipper, before and after cyclohex-
imide treatment, are presented in Fig. 5. Only the vN mutant
disappeared from the cells after cycloheximide treatment. In
contrast, wild-type NEFA, vL and vEAE were retained in the
Golgi longer than 4 h following cycloheximide treatment.
Fig. 3. Deletion mutants of the NEFA^GFP fusion protein. Numbers indicate the amino acid positions. Boxes signify the sequence motifs, sol-
id lines the intervals. Dotted lines indicate the deleted regions, de¢ned by the de¢cient ¢rst and last amino acids, which are denoted. Sp, signal
peptide; N, Leu/Ile-rich region; B, basic region; EF1, EF-hand 1; A, acidic region; EF2, EF-hand 2; EAE, EF-hand 1+acidic region+EF-
hand 2; L, leucine zipper region; LC, leucine zipper region+C-terminal region.
Fig. 4. Immunoblot of the expressed NEFA^GFP fusion protein
and the deletion mutant^GFP fusion proteins. At 24 h post-trans-
fection the HeLa cell lysates were supplied on 10% SDS^PAGE and
blotted on PVDF membrane. The proteins were detected with the
rabbit anti-NEFA pAb Gu1 and HRP-conjugated secondary anti-
bodies using ECL system. Lanes 1, NEFA; 2, vN; 3, vB; 4,
vEAE; 5, vEF1; 6, vEF2; 7, vL; 8, vLC; 9, GFP; 10, untrans-
fected HeLa cells. The protein band at 55 kDa is the endogenous
NEFA.
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Other mutants as vB, vEF1, vEF2 and vLC also persisted in
the Golgi (data not shown). The results indicate that NEFA is
a Golgi-resident protein and that its Golgi retention signal is
located in the N-terminal Leu/Ile-rich region.
4. Discussion
The NEFA homologs rat NUC, named CALNUC [9] and
insect CALNUC [14] have been identi¢ed as Golgi-resident
proteins, however their retention mechanisms are unknown.
Both proteins, NEFA and NUC (CALNUC), contain neither
transmembrane segments, nor a C-terminal KDEL tetrapep-
tide, which could mediate binding to ERD2, the KDEL re-
ceptor in the Golgi complex [16,19,20].
Recently, the soluble Ca2-binding EF-hand proteins retic-
ulocalbin, calumenin, ERC-55 (synonym TCBP-49 or E6BP),
Cab45 and CBP-50, were described as luminal proteins of the
Golgi and the ER of mammalian cells [21]. These proteins are
characterized by C-terminal HEEF, HDEF or HDEL tetra-
peptides, which are de¢ned as retention signals in the secre-
tory pathway. Cab45 is strictly localized in the Golgi compart-
ments and it contains a C-terminal HEEF motif [22].
However, both NEFA and NUC lack any of these C-terminal
tetrapeptides. It is also excluded that NEFA via palmitoyla-
Fig. 5. The expression of NEFA^GFP fusion protein and the deletion mutants in HeLa cells before and after cycloheximide treatment, detected
by £uorescence microscopy. At 24 h post-transfection the cells were treated with cycloheximide and incubated continuously at 37‡C. a: un-
treated, b: 2 h and c: 4 h after cycloheximide treatment.
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tion or myristoylation may be attached to Golgi membranes,
like eNOS [23], SCG10 [24] and GKi3 [25], because NEFA is a
cysteine-free protein and also a myristoylation motif is absent
from its N-terminus.
NEFA and NUC proteins are highly conserved proteins.
The strong amino acid sequence homology is not restricted
to vertebrates, but includes also invertebrates, spanning about
830 million years of evolutionary distance of Drosophila and
humans from their common ancestor [26].
Fig. 6 shows the alignment of the NEFA and NUC sequen-
ces corresponding to the N-terminal Leu/Ile-rich region of
human NEFA, amino acid position (a.p.) 25^170, which by
the above described experiments was de¢ned as relevant for
Golgi retention. The amino acid sequences homologous to
a.p. 70^123 are predominantly consensus in these proteins.
The segments, as shown in Fig. 6, by their alternating hydro-
phobic and charged amino acid residues may share similar
structural characteristics. The peptide stretch typed in red is
proposed as the putative Golgi retention motif of human
NEFA. This would constitute a novel Golgi retention motif,
preserved in the NEFA/NUC protein family members since
early metazoan evolution.
Finally, we ¢nd that NEFA is ubiquitously expressed in
cells from early embryonal stages as well as in adult tissues
and in the various cell lines we studied.
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